SCHEMBL6877992

SCHEMBL6877992

CCCc1cc(N(N)C(=O)OC(C)(C)C)ccc1C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLQ O75417 5/20 0.37
NR1H2 P55055 3/20 0.37
NR1H3 Q13133 3/20 0.37
RXRA P19793 2/20 0.37
CACNA1G O43497 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNA1C Q13936 1/20 0.34
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
AR P10275 3/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6879592 0.91 NR1H2 (0.39) POLQNR1H2NR1H3RXRACACNA1G
SCHEMBL7046151 0.81 THRA (0.36) NR1H2NR1H3RXRACACNA1GCACNA1B
SCHEMBL6879948 0.81 KIF11 (0.40) NR1H2NR1H3RXRACACNA1GCACNA1B
SCHEMBL17336857 0.81 LMNA (0.36) POLQNR1H2NR1H3RXRACACNA1G
SCHEMBL6879931 0.79 MRGPRX4 (0.37) NR1H2NR1H3RXRACACNA1GCACNA1B
SCHEMBL6878671 0.78 LMNA (0.36) POLQNR1H2NR1H3RXRACACNA1G
SCHEMBL6623841 0.78 RXRA (0.37) NR1H2NR1H3RXRACACNA1GCACNA1B
SCHEMBL6881686 0.77 KDR (0.41) LMNAS1PR1
SCHEMBL6624271 0.75 AAK1 (0.37) NR1H2NR1H3RXRACACNA1GCACNA1B
SCHEMBL2529611 0.73 MT-CO2 (0.42) KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-A1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-10 EP disclosed
WO-2003066623-A1 DIHYDROBENZODIAZEPIN-2-ONE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 WO disclosed